loading
Schlusskurs vom Vortag:
$3.28
Offen:
$3.28
24-Stunden-Volumen:
125.44K
Relative Volume:
0.37
Marktkapitalisierung:
$124.23M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-42.05M
KGV:
-1.1418
EPS:
-2.82
Netto-Cashflow:
$-35.26M
1W Leistung:
+2.22%
1M Leistung:
-10.06%
6M Leistung:
-9.04%
1J Leistung:
+15.41%
1-Tages-Spanne:
Value
$3.20
$3.34
1-Wochen-Bereich:
Value
$3.02
$3.36
52-Wochen-Spanne:
Value
$1.595
$10.48

Protara Therapeutics Inc Stock (TARA) Company Profile

Name
Firmenname
Protara Therapeutics Inc
Name
Telefon
646-844-0337
Name
Adresse
345 PARK AVENUE SOUTH, NEW YORK, NY
Name
Mitarbeiter
33
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-05
Name
Neueste SEC-Einreichungen
Name
TARA's Discussions on Twitter

Vergleichen Sie TARA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
TARA
Protara Therapeutics Inc
3.22 121.53M 0 -42.05M -35.26M -2.82
Biotechnology icon
ONC
Beone Medicines Ltd Adr
258.27 26.01B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
445.85 114.30B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.3499 41.83M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
83.98 6.29B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
484.93 63.90B 14.09B 4.50B 2.96B 39.28

Protara Therapeutics Inc Stock (TARA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-16 Eingeleitet Scotiabank Sector Outperform
2025-03-14 Eingeleitet Cantor Fitzgerald Overweight
2023-07-10 Fortgesetzt Guggenheim Buy
2021-06-04 Eingeleitet H.C. Wainwright Buy
2021-02-17 Eingeleitet Oppenheimer Outperform
2020-10-19 Eingeleitet Cowen Outperform
2020-07-29 Eingeleitet Guggenheim Buy
Alle ansehen

Protara Therapeutics Inc Aktie (TARA) Neueste Nachrichten

pulisher
Jun 03, 2025

Millennium Management LLC Purchases 357,051 Shares of Protara Therapeutics, Inc. (NASDAQ:TARA) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Protara Therapeutics names new Chief Commercial Officer By Investing.com - Investing.com South Africa

Jun 03, 2025
pulisher
Jun 02, 2025

Protara Therapeutics (TARA) Appoints New Chief Commercial Officer | TARA Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Protara Therapeutics names new Chief Commercial Officer - Investing.com

Jun 02, 2025
pulisher
Jun 02, 2025

Protara Therapeutics Names William Conkling as Chief Commercial Officer - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

Protara Therapeutics Announces Appointment Of William Conkling As Chief Commercial Officer - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

Protara Therapeutics Announces Appointment of William Conkling as Chief Commercial Officer | TARA Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Protara Therapeutics Announces Appointment of William Conkling as Chief Commercial Officer - GlobeNewswire

Jun 02, 2025
pulisher
Jun 02, 2025

Cancer Drug Veteran Behind Trodelvy Launch Joins Protara as Commercial Chief to Lead Market Strategy - Stock Titan

Jun 02, 2025
pulisher
May 29, 2025

Transcript : Protara Therapeutics, Inc. Presents at TD Cowen's 6th Annual Oncology Innovation Summit, May-27-2025 01 - marketscreener.com

May 29, 2025
pulisher
May 22, 2025

Jones Trading Initiates Coverage of Protara Therapeutics (TARA) with Buy Recommendation - Nasdaq

May 22, 2025
pulisher
May 22, 2025

Protara Therapeutics (TARA) Initiates Coverage with a Buy Rating - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Protara Therapeutics (TARA) Initiates Coverage with a Buy Rating | TARA Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Protara Therapeutics (TARA) Receives Buy Rating with $21 Price T - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Jones Initiates Protara Therapeutics at Buy With $21 Price Target - marketscreener.com

May 22, 2025
pulisher
May 22, 2025

Richard Levy Spends US$64k On Protara Therapeutics Stock - Yahoo Finance

May 22, 2025
pulisher
May 22, 2025

BNP Paribas Financial Markets Purchases Shares of 151,906 Protara Therapeutics, Inc. (NASDAQ:TARA) - Defense World

May 22, 2025
pulisher
May 18, 2025

Dimensional Fund Advisors LP Makes New $111,000 Investment in Protara Therapeutics, Inc. (NASDAQ:TARA) - Defense World

May 18, 2025
pulisher
May 17, 2025

Richard Levy Bought 65% More Shares In Protara Therapeutics - simplywall.st

May 17, 2025
pulisher
May 17, 2025

Insider Buying: Richard Levy Acquires 20,000 Shares of Protara T - GuruFocus

May 17, 2025
pulisher
May 16, 2025

With 73% ownership, Protara Therapeutics, Inc. (NASDAQ:TARA) boasts of strong institutional backing - Yahoo Finance

May 16, 2025
pulisher
May 13, 2025

Protara Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewswire

May 13, 2025
pulisher
May 11, 2025

Protara Therapeutics, Inc. (NASDAQ:TARA) Receives Average Rating of “Buy” from Brokerages - Defense World

May 11, 2025
pulisher
May 10, 2025

Protara Therapeutics Reports Q1 2025 Financial Results - TipRanks

May 10, 2025
pulisher
May 09, 2025

Protara Therapeutics: Q1 Earnings Snapshot - New Haven Register

May 09, 2025
pulisher
May 09, 2025

Barclays PLC Takes $492,000 Position in Protara Therapeutics, Inc. (NASDAQ:TARA) - Defense World

May 09, 2025
pulisher
May 08, 2025

Protara Therapeutics Announces First Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire

May 08, 2025
pulisher
May 08, 2025

Protara Therapeutics’ TARA-002: A Promising Alternative for NMIBC with Strong Efficacy and Safety Profile - TipRanks

May 08, 2025
pulisher
May 08, 2025

Protara (TARA) Strengthens Leadership with Key Appointments | TA - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Protara Therapeutics (TARA) Sees Positive Results in TARA-002 Trial | TARA Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Protara (TARA) Strengthens Leadership with Key Appointments | TARA Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Protara Therapeutics Q1 2025 Financial Results and Business Update - TradingView

May 08, 2025
pulisher
May 08, 2025

Protara Therapeutics, Inc. SEC 10-Q Report - TradingView

May 08, 2025
pulisher
May 08, 2025

Protara Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 08, 2025
pulisher
May 02, 2025

Geode Capital Management LLC Buys 9,553 Shares of Protara Therapeutics, Inc. (NASDAQ:TARA) - Defense World

May 02, 2025
pulisher
May 02, 2025

Renaissance Technologies LLC Sells 194,440 Shares of Protara Therapeutics, Inc. (NASDAQ:TARA) - Defense World

May 02, 2025
pulisher
May 01, 2025

Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

May 01, 2025
pulisher
May 01, 2025

Protara Therapeutics Expands Leadership Team: New CPO Receives 61,500 Equity Awards Amid Growth Push - Stock Titan

May 01, 2025
pulisher
May 01, 2025

Stocks of Protara Therapeutics Inc (TARA) are poised to climb above their peers - Sete News

May 01, 2025
pulisher
Apr 30, 2025

It would be worthwhile to take a closer look at Protara Therapeutics Inc (TARA) - uspostnews.com

Apr 30, 2025
pulisher
Apr 30, 2025

Protara Therapeutics, Inc.'s (NASDAQ:TARA) institutional investors lost 14% last week but have benefitted from longer-term gains - simplywall.st

Apr 30, 2025
pulisher
Apr 30, 2025

Protara Therapeutics, Inc. (NASDAQ:TARA) Shares Sold by LPL Financial LLC - Defense World

Apr 30, 2025
pulisher
Apr 29, 2025

The Potential Rise in the Price of Protara Therapeutics Inc (TARA) following insiders activity - knoxdaily.com

Apr 29, 2025
pulisher
Apr 29, 2025

Biotech Co. Achieves Remarkable Cancer Treatment Results in Trial - streetwisereports.com

Apr 29, 2025
pulisher
Apr 29, 2025

Protara Therapeutics Inc Inc. (TARA) Price Performance: A Technical Analysis Perspective - investchronicle.com

Apr 29, 2025
pulisher
Apr 29, 2025

Balance Sheet Breakdown: Protara Therapeutics Inc (TARA)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - DWinneX

Apr 29, 2025
pulisher
Apr 29, 2025

Protara Therapeutics (NASDAQ:TARA) Given “Buy” Rating at HC Wainwright - Defense World

Apr 29, 2025
pulisher
Apr 28, 2025

Protara Therapeutics stock drops following interim trial results By Investing.com - Investing.com Nigeria

Apr 28, 2025

Finanzdaten der Protara Therapeutics Inc-Aktie (TARA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$1.16
price up icon 0.00%
$573.50
price down icon 0.54%
$36.08
price up icon 15.90%
$305.31
price up icon 0.51%
$4.75
price up icon 3.70%
$484.93
price down icon 0.60%
Kapitalisierung:     |  Volumen (24h):